AGP Executive Report
Last update: 5 hours agoBiotech: New Haven-based Arvinas has begun dosing patients in an early-stage trial of an experimental cancer drug and reported promising biomarker changes in a separate Parkinson’s disease study. Cybersecurity: Connecticut is investing in cyber protections for the state’s defense industry, a move aimed at safeguarding a key part of its technology economy. AI and education: Connecticut leaders are touting workforce training and partnerships with higher education to build AI skills; a Trinity College symposium also examined how AI may affect learning, with researchers stressing the importance of active practice and repetition. Medical research: Jackson Laboratory scientists have identified pain pathways involved in endometriosis, offering new leads for understanding the disease.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.